Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Nanotechnology|December 4, 2020
Novel rivaroxaban-loaded poly(lactic-co-glycolic acid)/poloxamer nanoparticles: preparation, physicochemical characterization, in vitro evaluation of time-dependent anticoagulant activity and toxicological profileMonique Etnea Machado, Priscila de Souza Furtado, Cristina da Costa Bernardes Araújo, et al.
International Journal of Cosmetic Science|February 8, 2023
Development of SEDDS formulation containing caffeine for dermal deliveryIgor de Andrade Assunção de Almeida, Thiago da Silva Honório, Flavia Almada do Carmo, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Design, Synthesis, and Biological Evaluation of Novel Multitarget 7-Alcoxyamino-3-(1,2,3-triazole)-coumarins as Potent Acetylcholinesterase InhibitorsNathalia F Nadur, Larissa de A P Ferreira, Daiana P Franco, et al.
Biomedical Chromatography : BMC|March 20, 2020
Forced degradation studies of norepinephrine and epinephrine from dental anesthetics: Development of stability-indicating HPLC method and in silico toxicity evaluationLetícia Coli Louvisse de Abreu, Bárbara de Azevedo Abrahim-Vieira, Alessandra Mendonça Teles de Souza, et al.
Colloids and Surfaces. B, Biointerfaces|July 22, 2021
Development of rivaroxaban microemulsion-based hydrogel for transdermal treatment and prevention of venous thromboembolismCristina da Costa Bernardes Araújo, Alice Simon, Thiago da Silva Honório, et al.
Current Medicinal Chemistry|February 4, 2024
<i>N,N'</i>-disubstituted Ureas as Novel Antiplatelet Agents: Synthesis, Pharmacological Evaluation and <i>In Silico</i> StudiesPriscila de Souza Furtado, Gil Mendes Viana, Alana Agnes Silva Camargo de Oliveira, et al.
Pharmaceutics|May 25, 2024
Evaluation of Silybin Nanoparticles against Liver Damage in Murine <i>Schistosomiasis mansoni</i> InfectionDaniel Figueiredo Vanzan, Ester Puna Goma, Fernanda Resende Locatelli, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Synthesis and Evaluation of Antiproliferative Activity, Topoisomerase IIα Inhibition, DNA Binding and Non-Clinical Toxicity of New Acridine-Thiosemicarbazone DerivativesGleyton Sousa, Maria C F de Almeida, Lucas L Lócio, et al.
European Journal of Medicinal Chemistry|November 12, 2024
Discovery of novel thiosemicarbazone-acridine targeting butyrylcholinesterase with antioxidant, metal complexing and neuroprotector abilities as potential treatment of Alzheimer's disease: In vitro, in vivo, and in silico studiesGleyton Leonel Silva Sousa, Nathalia Fonseca Nadur, Larissa de Almeida Peixoto Ferreira, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 30, 2023
In vivo evaluation of time-dependent antithrombotic effect of rivaroxaban-loaded poly(lactic-co-glycolic acid)/sodium lauryl sulfate or didodecyl dimethylammonium bromide nanoparticles in Wistar ratsPriscila de Souza Furtado, Alana Agnes Silva Camargo de Oliveira, Pryscila Santiago Rodrigues, et al.
Pageof 5